Biomarkers are well known for their role in exploring diagnostics; but what role can RNA biomarkers play in drug discovery and development and how are they improving workflows for researchers?

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

We’re in the midst of a paradigm shift in biomarker science. Once considered exploratory, biomarker signatures have evolved into strategic assets - tools that actively de-risk decision-making across ...

In this interview, industry expert Phillip Mitchell discusses the role of NfL biomarkers in CNS drug discovery, neurodegenerative disease research, treatment monitoring, neurotoxicity detection, and ...

Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways Extending their collaboration, Genialis and Debiopharm continue working towards a ...

As part of an educational series on qualifying biomarkers for use in drug development, the US Food and Drug Administration (FDA) has released two fictitious examples of how biomarkers can improve the ...

LAS VEGAS -- April 24, 2024 --The world of Alzheimer’s treatments is at an inflection point as more potential drugs make their way out of clinical trials. And on the heels of newly FDA-approved drugs ...

SINGAPORE & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Engine Biosciences, a company leveraging machine learning and high-throughput biology to discover and develop precision oncology medicines, today ...

Predictive Oncology Inc. has updated shareholders on its advancements in AI-driven drug discovery, specifically in biomarker discovery and drug repurposing, amid a growing biomarker discovery market ...